Sign inJoin waitlistJoin the waitlist

PB

Pooja Bhagia

Pediatrics

Credentials: · · ·

History

Pediatric Hematology/Oncology
New York Presbyterian Hospital
Pediatrics

Research

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
The Lancet · 2021 · 1,369 citations
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Journal of Clinical Oncology · 2020 · 909 citations
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
The Lancet Oncology · 2023 · 629 citations

CS
Chie-Schin Shih
9 papers
Manish Shah
7 papers
YJ
Yelena Janjigian
7 papers
Peter Enzinger
6 papers
Zev Wainberg
6 papers
CF
Charles Fuchs
5 papers
JC
Joseph Chao
3 papers
SB
Sonal Bordia
3 papers
Craig Lockhart
2 papers
DA
David Abramson
2 papers
ML
Maeve Lowery
2 papers
MG
Mukul Gupta
2 papers